Stock Scorecard



Stock Summary for Iradimed Corp (IRMD) - $100.18 as of 3/10/2026 7:58:43 PM EST

Total Score

14 out of 30

Safety Score

31 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for IRMD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for IRMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for IRMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for IRMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for IRMD (31 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 3
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for IRMD

IRMD Stock News Today | Earnings, Events & Price Alerts 2/28/2026 10:52:00 PM
Here’s What Offers IRadimed Corp. (IRMD) a Compelling Growth Trajectory 2/20/2026 8:10:00 AM
IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter 2/18/2026 12:57:00 PM
Allen Monty K sells IRADIMED (IRMD) shares worth $100,256 By Investing.com 2/17/2026 1:51:00 AM
IRADIMED Corp (IRMD) director sells 1,000 shares at $100.2563 2/16/2026 10:51:00 PM
Allen Monty K sells IRADIMED (IRMD) shares worth $100,256 By Investing.com 2/16/2026 1:57:00 AM
Allen Monty K sells IRADIMED (IRMD) shares worth $100,256 2/14/2026 2:52:00 AM
Director Monty Allen Sells 1,000 Shares of iRadimed Corp (IRMD) 2/14/2026 12:57:00 AM
IRADIMED Record Revenue Streak Supports 3870 Pump Rollout And Dividend Growth 2/13/2026 11:57:00 PM
IRADIMED Dividend Hike Follows Record Revenue And New MRI Pump Rollout 2/13/2026 11:04:00 PM

Financial Details for IRMD

Company Overview

Ticker IRMD
Company Name Iradimed Corp
Country N/A
Description IRADIMED CORPORATION develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories and services in the United States and internationally. The company is headquartered in Winter Springs, Florida.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 12/31/2025
Next Earnings Date 5/4/2026

Stock Price History

Last Day Price 100.18
Price 4 Years Ago 26.37
Last Day Price Updated 3/10/2026 7:58:43 PM EST
Last Day Volume 55,223
Average Daily Volume 67,620
52-Week High 107.69
52-Week Low 46.79
Last Price to 52 Week Low 114.11%

Valuation Measures

Trailing PE N/A
Industry PE 44.86
Sector PE 76.91
5-Year Average PE 38.35
Free Cash Flow Ratio 24.92
Industry Free Cash Flow Ratio 21.67
Sector Free Cash Flow Ratio 22.97
Current Ratio Most Recent Quarter 7.98
Total Cash Per Share 4.02
Book Value Per Share Most Recent Quarter 7.43
Price to Book Ratio 14.16
Industry Price to Book Ratio 3.96
Sector Price to Book Ratio 21.80
Price to Sales Ratio Twelve Trailing Months 15.19
Industry Price to Sales Ratio Twelve Trailing Months 3.36
Sector Price to Sales Ratio Twelve Trailing Months 4.55
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 12,721,200
Market Capitalization 1,274,409,816
Institutional Ownership N/A

Dividends

Ex-Dividend Date 2/23/2026
Previous Dividend Amount 0.5000
Current Dividend Amount 0.2000
Total Years Dividend Increasing 3
Trailing Annual Dividend Rate 1.04
Trailing Annual Dividend Yield 1.05%
Forward Annual Dividend Rate 0.80
Forward Annual Dividend Yield 0.81%
5-Year Dividend Payments Count 13
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio 59.43%

Income Statement

Quarterly Earnings Growth YOY 24.70%
Annual Earnings Growth 16.88%
Reported EPS 12 Trailing Months 1.75
Reported EPS Past Year 1.87
Reported EPS Prior Year 1.61
Net Income Twelve Trailing Months 22,480,042
Net Income Past Year 22,480,000
Net Income Prior Year 19,234,026
Quarterly Revenue Growth YOY 17.00%
5-Year Revenue Growth 21.45%
Operating Margin Twelve Trailing Months 31.30%

Balance Sheet

Total Cash Most Recent Quarter 51,159,000
Total Cash Past Year 51,159,000
Total Cash Prior Year 52,233,907
Net Cash Position Most Recent Quarter 51,159,000
Net Cash Position Past Year 51,159,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 94,618,000
Total Stockholder Equity Prior Year 86,818,756
Total Stockholder Equity Most Recent Quarter 94,618,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 16,806,013
Free Cash Flow Per Share Twelve Trailing Months 1.32
Free Cash Flow Past Year 17,182,000
Free Cash Flow Prior Year 17,619,430

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.55
MACD Signal 0.85
20-Day Bollinger Lower Band 81.24
20-Day Bollinger Middle Band 95.19
20-Day Bollinger Upper Band 109.15
Beta 1.10
RSI 44.17
50-Day SMA 74.32
150-Day SMA 55.28
200-Day SMA 49.36

System

Modified 3/10/2026 1:46:53 AM EST